ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04975	Fat digestion and absorption	2/10	35/7206	0.00100650335202
ko04622	RIG-I-like receptor signaling pathway	2/10	62/7206	0.00313546000829
ko05140	Leishmaniasis	2/10	75/7206	0.00455710014027
ko04657	IL-17 signaling pathway	2/10	87/7206	0.00608906450597
ko05133	Pertussis	2/10	87/7206	0.00608906450597
ko04917	Prolactin signaling pathway	2/10	87/7206	0.00608906450597
ko05222	Small cell lung cancer	2/10	89/7206	0.00636446240608
ko04064	NF-kappa B signaling pathway	2/10	96/7206	0.00737276544097
ko04620	Toll-like receptor signaling pathway	2/10	100/7206	0.00797963490294
ko05162	Measles	2/10	120/7206	0.0113406170801
ko05145	Toxoplasmosis	2/10	126/7206	0.0124525143974
ko05142	Chagas disease (American trypanosomiasis)	2/10	130/7206	0.0132196976802
ko04380	Osteoclast differentiation	2/10	134/7206	0.0140073774826
ko04080	Neuroactive ligand-receptor interaction	3/10	423/7206	0.0176815370925
ko05160	Hepatitis C	2/10	153/7206	0.0180225670997
ko04621	NOD-like receptor signaling pathway	2/10	157/7206	0.018924204639
ko04722	Neurotrophin signaling pathway	2/10	160/7206	0.019613011709
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	1/10	15/7206	0.0206348465182
ko05168	Herpes simplex infection	2/10	182/7206	0.0249856808978
ko05152	Tuberculosis	2/10	187/7206	0.0262836230284
ko05200	Pathways in cancer	3/10	492/7206	0.0264475069586
ko05169	Epstein-Barr virus infection	2/10	206/7206	0.0314652638741
ko00515	Mannose type O-glycan biosynthesis	1/10	25/7206	0.0341776765161
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1/10	28/7206	0.0382075280646
ko05320	Autoimmune thyroid disease	1/10	29/7206	0.0395474451339
ko04950	Maturity onset diabetes of the young	1/10	29/7206	0.0395474451339
ko01523	Antifolate resistance	1/10	30/7206	0.0408856819385
ko00514	Other types of O-glycan biosynthesis	1/10	30/7206	0.0408856819385
ko00052	Galactose metabolism	1/10	33/7206	0.0448903294934
ko04020	Calcium signaling pathway	2/10	265/7206	0.0498944796565